Keb Asset Management, LLC Pfizer Inc Transaction History

Keb Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $2,379 - $3,106	-57 Reduced 1.12%	5,039 $258,000
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $2,494 - $3,044	57 Added 1.13%	5,096 $223,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $1,418 - $1,757	-31 Reduced 0.61%	5,039 $261,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $209,492 - $310,537	5,070 New	5,070 $299,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Keb Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Keb Asset Management, LLC with notifications on news.